Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05700994

Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,283 (actual)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
18 Years – 105 Years
Healthy volunteers
Not accepted

Summary

The main goal of this study is to tests the effect of incentivizing achievement of self-identified, personal harm reduction goals (Contingency management or CM) compared with standard of care (peer harm reduction service with incentives for peer visits) to increase the reach and effectiveness of methamphetamine (MA) harm reduction services.

Detailed description

Using a hybrid type 1 effectiveness-implementation framework and stepped-wedge design, this study will randomize eighteen community-based peer harm reduction sites to provide contingency management incentives for achieving self-identified harm reduction goals set with peer specialists using a participant-driven harm reduction goal-setting process (e.g. completing overdose prevention and supply training, daily life goals, treatment and care goals, relationship and social support goals) versus standard of care contingency management (i.e. incentives for peer encounter attendance).

Conditions

Interventions

TypeNameDescription
BEHAVIORALPeer Contingency ManagementParticipants allocated to peer-facilitated contingency management will receive incentives for achieving self-identified harm reduction goals set with peer specialists using a participant-driven harm reduction goal-setting process (e.g. completing overdose prevention and supply training, daily life goals, treatment and care goals, relationship and social support goals)
BEHAVIORALStandard of Care Contingency ManagementParticipants allocated to standard of care contingency management will receive incentives for peer encounters.

Timeline

Start date
2023-11-13
Primary completion
2026-09-30
Completion
2026-09-30
First posted
2023-01-26
Last updated
2026-01-14

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05700994. Inclusion in this directory is not an endorsement.